Market cap
$844 Mln
Revenue (TTM)
$240 Mln
P/E Ratio
--
P/B Ratio
2.4
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 2.98 | 3.92 | -4.74 | -3.19 | 2.95 |
| EBIT | 21.78 | 0.36 | -41.61 | -261.54 | -274.47 |
| Net Profit | 25.80 | 12.03 | -31.15 | -250.06 | -256.03 |
| EPS | 25.80 | 14.23 | -29.54 | -238.07 | -249.50 |
| Book Value | -- | -- | -7.93 | 13.71 | 11.57 |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Jun-22 | Jun-21 |
| EBIT-Margin
| -10.36 | -5.96 | -16.08 | -15.16 | -4.61 |
| Net Margin
| -10.73 | -8.07 | -15.63 | -15.58 | -5.17 |
| Return on equity
| -10.75 | -6.21 | -15.49 | -14.19 | -4.97 |
| Return on Capital
| -9.89 | -5.73 | -- | -13.16 | -4.62 |
| Return on Assets
| -8.19 | -4.77 | -10.57 | -10.94 | -3.88 |
| Debt to Equity (x)
| -- | -- | 0.00 | 0.08 | 0.08 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Cardiovascular Systems (CSII)
|
--
|
-13.16
|
-4.62
|
-11.88
|
-0.16
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-15.49
Lower than Peers by 20.44
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Cardiovascular Systems (CSII)
|
-15.49
|
-14.19
|
-4.97
|
-13.07
|
-0.18
|
|
Peer Median
|
4.94
|
--
|
--
|
--
|
--
|
ROA
-10.57
Lower than Peers by 13.02
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Cardiovascular Systems (CSII)
|
-10.57
|
-10.94
|
-3.88
|
-9.76
|
-0.12
|
|
Peer Median
|
2.45
|
--
|
--
|
--
|
--
|
EBIT Margin
-16.08
Lower than Peers by 24.55
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Cardiovascular Systems (CSII)
|
-16.08
|
-15.16
|
-4.61
|
-11.32
|
-0.33
|
|
Peer Median
|
8.47
|
--
|
--
|
--
|
--
|
Net Margin
-15.63
Lower than Peers by 20.30
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Cardiovascular Systems (CSII)
|
-15.63
|
-15.58
|
-5.17
|
-11.43
|
-0.10
|
|
Peer Median
|
4.68
|
--
|
--
|
--
|
--
|
Cash Profit Margin
0.00
--
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Cardiovascular Systems (CSII)
|
0.00
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
-4.74
Lower than Peers by 13.22
Year on year growth in net sales
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Cardiovascular Systems (CSII)
|
-4.74
|
-0.09
|
0.09
|
-0.05
|
0.14
|
|
Peer Median
|
8.49
|
--
|
--
|
--
|
--
|
EBIT Growth
-41.61
Lower than Peers by 52.25
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Cardiovascular Systems (CSII)
|
-41.61
|
-200.06
|
55.43
|
-3,145.09
|
-123.17
|
|
Peer Median
|
10.65
|
--
|
--
|
--
|
--
|
Net Profit Growth
-31.15
Lower than Peers by 44.70
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Cardiovascular Systems (CSII)
|
-31.15
|
-175.19
|
50.72
|
-10,580.78
|
-114.89
|
|
Peer Median
|
13.55
|
--
|
--
|
--
|
--
|
EPS Growth
-29.54
Lower than Peers by 50.05
Year on year growth in earnings per share
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Cardiovascular Systems (CSII)
|
-29.54
|
-1.75
|
0.57
|
-105.81
|
-1.15
|
|
Peer Median
|
20.51
|
--
|
--
|
--
|
--
|
Book Value Growth
-10.06
Lower than Peers by 17.07
Year on year growth in book value per share
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Cardiovascular Systems (CSII)
|
-10.06
|
--
|
--
|
--
|
--
|
|
Peer Median
|
7.01
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Cardiovascular Systems (CSII)
|
--
|
0.08
|
0.08
|
0.08
|
0.14
|
|
Peer Median
|
0.40
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
--
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Cardiovascular Systems (CSII)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
6.04
Higher than Peers by 3.21
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Cardiovascular Systems (CSII)
|
6.04
|
6.05
|
5.21
|
6.46
|
4.25
|
|
Peer Median
|
2.83
|
--
|
--
|
--
|
--
|
Quick Ratio
4.92
Higher than Peers by 2.87
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Cardiovascular Systems (CSII)
|
4.92
|
5.19
|
4.62
|
5.84
|
3.83
|
|
Peer Median
|
2.05
|
--
|
--
|
--
|
--
|
Interest Coverage
-22.22
Lower than Peers by 27.18
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Cardiovascular Systems (CSII)
|
-22.22
|
-21.91
|
-6.88
|
-13.57
|
-0.49
|
|
Peer Median
|
4.96
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
16.77
Higher than Peers by 0.32
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Cardiovascular Systems (CSII)
|
16.77
|
16.80
|
15.46
|
10.66
|
14.52
|
|
Peer Median
|
16.46
|
--
|
--
|
--
|
--
|
Asset Turnover
0.67
Higher than Peers by 0.17
Sales / Average Total Assets
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Cardiovascular Systems (CSII)
|
0.67
|
0.70
|
0.75
|
0.85
|
1.18
|
|
Peer Median
|
0.50
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Cardiovascular Systems (CSII)
|
--
|
61.63
|
46.01
|
47.27
|
49.51
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Cardiovascular Systems (CSII)
|
--
|
192.53
|
179.30
|
171.41
|
132.77
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Cardiovascular Systems (CSII)
|
--
|
81.88
|
76.48
|
85.15
|
82.87
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Cardiovascular Systems (CSII)
|
--
|
172.27
|
148.83
|
133.53
|
99.41
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
--
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Cardiovascular Systems (CSII)
|
--
|
-15.16
|
-123.94
|
-39.39
|
-5,724.00
|
|
Peer Median
|
44.46
|
--
|
--
|
--
|
--
|
Price / Book Value
2.43
Lower than Peers by 1.36
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Cardiovascular Systems (CSII)
|
2.43
|
2.24
|
6.14
|
3.99
|
9.87
|
|
Peer Median
|
3.79
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Cardiovascular Systems (CSII)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
-14.49
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Cardiovascular Systems (CSII)
|
-14.49
|
-12.20
|
-137.81
|
-33.73
|
518.09
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
844
Higher than Peers by 304
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Jun-22
|
Jun-21
|
Jun-20
|
Jun-19
|
|---|---|---|---|---|---|
|
Cardiovascular Systems (CSII)
|
844
|
--
|
--
|
--
|
--
|
|
Peer Median
|
540
|
--
|
--
|
--
|
--
|